Key result
Catheter ablation appears superior to antiarrhythmic drug therapy for rhythm control, though studies after 2011 showed less efficacy and higher adverse events.
Why the study?
Does catheter ablation improve efficacy and safety for rhythm control in patients with atrial fibrillation compared to antiarrhythmic drug therapy?
Meta-Analysis
Does catheter ablation improve efficacy and safety for rhythm control in patients with atrial fibrillation compared to antiarrhythmic drug therapy?
Catheter ablation is superior to antiarrhythmic drugs for rhythm control in atrial fibrillation, although recent studies suggest a higher rate of adverse events.
Answers are grounded in this paper and cite their sources.
Caution advised for ablation given higher recent adverse events; challenges earlier evidence of consistent superiority over drugs.
OBJECTIVE: To evaluate the trend of change in the efficacy and safety of catheter ablation compared with antiarrhythmic drug therapy (ADT) for rhythm control in patients with atrial fibrillation (AF) over time. METHODS: The online databases PubMed and EMBASE were searched for relevant studies. STATA software (version 12.0) was used to perform the meta-analysis and meta-regression. RESULTS: . 7.3%; RR = 1.08, 95% CI: 1.04-1.13) in studies after 2011. CONCLUSIONS: Catheter ablation appears to be superior to ADT for rhythm control. However, less efficacy and a higher rate of adverse events were observed in studies after 2011 compared to studies before 2011.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2018) conducted a meta-analysis in Atrial fibrillation. Catheter ablation vs. Antiarrhythmic drug therapy (ADT) was evaluated on Efficacy and safety for rhythm control (RR 1.08, 95% CI 1.04-1.13). Catheter ablation appears superior to antiarrhythmic drug therapy for rhythm control, though studies after 2011 showed less efficacy and higher adverse events.
Synapse has enriched 10 related papers. Consider them for comparative context: